Published in Rheumatol Int on March 30, 2013
Psychophysical bases of perceived exertion. Med Sci Sports Exerc (1982) 30.13
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum (1984) 20.51
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis (1991) 13.67
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol (1994) 11.17
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol (1994) 8.61
The six-minute walk test. Respir Care (2003) 3.79
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol (1996) 1.73
Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis (1986) 1.16
Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis (1990) 1.11
Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study. Arthritis Res Ther (2012) 1.06
Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol (2005) 1.05
Diaphragmatic contribution to ventilation in patients with ankylosing spondylitis. Respiration (1971) 1.04
Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol (2006) 1.00
Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin Rheumatol (2004) 0.97
Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). Ann Rheum Dis (2011) 0.93
The pulmonary involvement in rheumatic diseases: pulmonary effects of ankylosing spondylitis and its impact on functionality and quality of life. Tohoku J Exp Med (2007) 0.90
Pleuropulmonary involvement in ankylosing spondylitis. Joint Bone Spine (2005) 0.89
Relationship between pulmonary function and exercise tolerance in patients with ankylosing spondylitis. Clin Exp Rheumatol (2000) 0.86
An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis. Respir Med (1999) 0.82
Lumbar stiffness but not thoracic radiographic changes relate to alteration of lung function tests in ankylosing spondylitis. Clin Rheumatol (2002) 0.80
Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis. Clin Rheumatol (2004) 0.77
Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol (1995) 1.79
Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol (1998) 1.54
Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol (2006) 1.45
Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis. Lupus (2011) 1.00
Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98
Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol (1999) 0.96
Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus. Lupus (2004) 0.92
Two year followup of anterior and vertical atlantoaxial subluxation in ankylosing spondylitis. J Rheumatol (1997) 0.91
Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. J Rheumatol (1998) 0.90
Use of alternative therapies by patients with rheumatic disease in Guadalajara, Mexico: prevalence, beliefs, and expectations. Arthritis Care Res (1998) 0.86
Association analysis of vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Mexican-Mestizo women. Genet Mol Res (2013) 0.85
The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study. Clin Dev Immunol (2013) 0.84
Autonomic dysfunction in patients with systemic lupus erythematosus. J Rheumatol (1998) 0.83
Mixed connective tissue disease. A clinico-serological study of 17 cases. Mol Biol Rep (1996) 0.82
Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus. Rheumatology (Oxford) (2005) 0.82
Subacute renal failure in diabetic nephropathy due to endocapillary glomerulonephritis and cholesterol embolization. J Nephrol (2008) 0.81
Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol (2001) 0.81
Serum IgG activity against cyclic citrullinated peptide in patients evaluated for rheumatoid factor correlates with the IgM isotype. Rheumatol Int (2008) 0.80
Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J Rheumatol (2000) 0.80
Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial. J Rheumatol (1997) 0.80
Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases. Pharmacogenomics J (2010) 0.80
Serum oxidative stress is increased in patients with post cholecystectomy bile duct injury. Rev Esp Enferm Dig (2010) 0.79
Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with preeclampsia/eclampsia. Blood Cells Mol Dis (2005) 0.79
Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol (1997) 0.79
Metabolic profile and insulin sensitivity in healthy young Mexicans with a strong family history of non-insulin-dependent diabetes mellitus in the paternal branch. Arch Med Res (1997) 0.78
Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis. J Rheumatol (1995) 0.77
Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection. Clin Exp Rheumatol (2011) 0.77
Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. J Rheumatol (1997) 0.77
Leflunomide in the treatment of psoriasis: results of a phase II open trial. Br J Dermatol (2004) 0.75
Acquired ichthyosis associated with systemic lupus erythematosus. Lupus (2004) 0.75
Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. Rheumatol Int (2005) 0.75
The ACTN3 R577X polymorphism is associated with inflammatory myopathies in a Mexican population. Scand J Rheumatol (2012) 0.75
Prescription for antiresorptive therapy in Mexican patients with rheumatoid arthritis: is it time to reevaluate the strategies for osteoporosis prevention? Rheumatol Int (2012) 0.75
[Mild preeclampsia and serum insulin values in the third pregnancy trimester]. Ginecol Obstet Mex (1998) 0.75
Anticardiolipin antibodies and the severity of preeclampsia-eclampsia. Gynecol Obstet Invest (1999) 0.75